1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6994DA974F24766E585256E9F004EFCA5
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/measuring-medical-affairs-performance?opendocument
18
19opendocument
203.234.214.113
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Medical Affairs Medical Affairs Excellence

Measuring Medical Affairs Performance

DB Image

ID: 4632


Features:

Metrics, Graphics, Summary Matrix


Pages/Slides: 5


Published: Pre-2014


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Study Overview

While the medical affairs function arguably plays the most crucial role in the success or failure of a pharmaceutical company, investments made to this function are hard to measure in terms of return on investment. This five-page document looks at what tactics top companies are using to measure the efficiency and effectiveness of their medical affairs function. There exists a variety of measures that can be used to gauge performance even if investment is not linked to overall profitability. This document also includes a matrix chart containing medical affairs capabilities and the quantitative and qualitative measures used to assess each.

Key Metrics
Qualitative and quantitative types of measurements in specific medical affairs areas include:
-Overall medical affairs
*A quantitative form of measurement for this area is adherence to budget.
-Medical Research
*For this area, a qualitative type of measurement is feedback from stakeholders on information/data.
-Medical Communications/Writing
*Whether or not the publishing deadlines were met is a quantitative form of measurement for this area.

Methodology
This document results from a Best Practices, LLC consulting project performed on behalf of a pharmaceutical client.


Industries Profiled:
Health Care; Pharmaceutical; Diagnostic; Biotech; Medical Device


Companies Profiled:
Abbott; Sanofi-aventis; Amgen; AstraZeneca; Eli Lilly; Janssen; Schering-Plough; GlaxoSmithKline; Roche; Merck

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.